Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × tipifarnib × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 3 Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Pheochromocytoma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma 1 Histiocytic Sarcoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Central Nervous System Neoplasms 1

Interventions

ruxolitinib 19 Cyclophosphamide 11 Whole-Body Irradiation 9 Tacrolimus 8 fludarabine phosphate 7 fludarabine 7 Stem Cell Transplantation 7 Mycophenolic Acid 7 Specimen Handling 6 Peripheral Blood Stem Cell Transplantation 6 Azacitidine 5 Melphalan 4 Busulfan 4 Biopsy 4 fedratinib 3 Sirolimus 3 Methotrexate 3 Injections 3 venetoclax 2 selinexor 2 navitoclax 2 luspatercept 2 letermovir 2 itacitinib 2 bomedemstat 2 INCB057643 2 INCB039110 2 Hematopoietic Stem Cell Transplantation 2 Decitabine 2 Cyclosporine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡